HealthStream, Inc. — Q1 2024 Form 10-Q
Reporting period: Three months ended March 31, 2024. HealthStream provides primarily SaaS applications for healthcare organizations, supporting learning, clinical development, credentialing, and scheduling through its hStream platform. Figures below are in U.S. dollars; financial statement amounts are in millions unless noted.
Financial performance
| Metric | Q1 2024 | Q1 2023 | Change |
|---|---|---|---|
| Revenue | $72.8 | $68.9 | +6% |
| Operating income | $5.7 | $2.9 | +97% |
| Net income | $5.2 | $2.6 | +99% |
| Diluted EPS | $0.17 | $0.09 | Up $0.08 |
| Adjusted EBITDA (non-GAAP) | $17.1 | $13.7 | +24% |
| Cash from operating activities | $20.9 | $20.5 | +$0.4 |
Subscription revenue rose 6% to $70.2 million, while professional services revenue fell 13% to $2.6 million. Subscription services represented 96% of revenue in both periods. Cost of revenue, excluding depreciation and amortization, was 34% of revenue versus 35%; operating margin was approximately 7.8% versus 4.2%, and net margin approximately 7.2% versus 3.8%.
Operating cash flow was supported by $14.6 million of growth in deferred revenue, partly offset by increases in receivables and reductions in accounts payable and accrued expenses. Capital expenditures, as defined by the company, were $7.8 million, compared with $8.4 million a year earlier.
Liquidity, debt, and capital allocation
- At March 31, cash and cash equivalents were $52.4 million and marketable securities were $31.3 million, totaling $83.7 million. Working capital was $21.3 million, up from $11.8 million at year-end 2023.
- No borrowings were outstanding under the unsecured revolving credit facility, which permits up to $50 million of borrowing, subject to its terms and covenants, and matures October 6, 2026. The company reported compliance with all covenants.
- The company paid $0.8 million in quarterly dividends and declared a further $0.028-per-share dividend after quarter-end. Its $10 million share repurchase program expired March 31, 2024; no shares were repurchased in Q1. Cumulative repurchases under the program were 404,188 shares for $8.9 million.
Material changes and management commentary
Revenue growth came from subscriptions, partly offset by lower professional services revenue. Operating income growth reflected the higher revenue base and lower general and administrative costs; cost of revenue and product development expenses increased, while depreciation and amortization also rose. Other income increased to $0.9 million, primarily due to higher interest income on cash and investments. The effective tax rate rose to 20% from 16%.
Management cited continuing inflationary pressures, elevated interest rates, labor-market challenges, and geopolitical uncertainty, which have increased costs for the company and customers and may adversely affect results. It described the direct COVID-19 impact as having significantly lessened, while continuing to monitor public-health developments.
Outlook, risks, and notable items
- No specific revenue, earnings, or other full-year financial guidance is provided in the filing. Management believes cash, investments, operating cash generation, and available credit will be sufficient for anticipated needs for at least the next 12 months.
- Remaining performance obligations were approximately $514 million; the company expects to recognize about 44% over the next 12 months, with the balance thereafter. This is contracted revenue, not a forecast of total company revenue.
- Adjusted EBITDA is a non-GAAP measure. Beginning in 2024, the company no longer includes deferred-revenue write-downs from pre-2022 acquisitions as an adjustment; Q1 2023 included a $50,000 adjustment, so the measure’s calculation differs between periods.
- Market risks include interest-rate exposure on cash and investments, foreign-currency fluctuations, and volatility or impairment risk in strategic private-company investments. The company estimated that a hypothetical 10% decrease in interest rates would reduce annualized interest income by approximately $0.4 million.
- The filing reports no material changes to previously disclosed risk factors and no legal proceedings. Management reported effective disclosure controls and no material Q1 change in internal control over financial reporting.
Important facts for investors to verify
- Whether subscription growth continues and whether professional services revenue stabilizes or declines further.
- How much of the $514 million in remaining performance obligations converts to recognized revenue, and on what timetable.
- Whether operating cash flow remains strong as deferred revenue, receivables, and accrued liabilities change.
- Whether margin improvement is sustained amid higher cloud-hosting, royalty, software, labor, and amortization costs.
- Future dividend and capital-allocation decisions, including any new share repurchase program or acquisitions.
- Compliance with revolving-credit covenants and the availability and cost of borrowing if financing is needed.